Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day.

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

Researchers unveiled a genetic editing method that uses small nuclear RNAs instead of CRISPR. This approach produced fewer ...